medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2025, Número 3

<< Anterior Siguiente >>

Rev Mex Urol 2025; 85 (3)


Una revisión exploratoria sobre la implantación temprana de prótesis de pene en el tratamiento del priapismo isquémico refractario

Uribe Bayona AJ, García-Perdomo HA

Idioma: Ingles.
Referencias bibliográficas: 38
Paginas: 1-11
Archivo PDF: 167.58 Kb.


RESUMEN

Objetivo: describir el estado actual de las indicaciones, complicaciones, efectos adversos, opciones terapéuticas e inserción temprana vs. tardía en pacientes con priapismo refractario sometidos a implante de prótesis de pene.
Métodos: se realizaron búsquedas en MEDLINE (OVID), EMBASE y el Registro Cochrane Central de Ensayos Controlados (CENTRAL) desde su inicio hasta la actualidad. También se consultaron guías de práctica clínica accesibles de Norteamérica, Europa, Sudáfrica y Japón.
Resultados: la búsqueda en diversos motores de búsqueda arrojó 255 artículos, de los cuales 12 se seleccionaron tras eliminar duplicados, artículos no relacionados y estudios no realizados en humanos.
Conclusión: el uso temprano de prótesis peneanas es una opción viable en el priapismo isquémico refractario al tratamiento de primera línea, disminuyendo el riesgo de eventos adversos relacionados con implantes tardíos y brindando a los pacientes la posibilidad de preservar la función sexual y, al mismo tiempo, brindar terapia a una patología inusual con comorbilidad significativa.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Montague DK, Jarow J, Broderick GA,Dmochowski RR, Heaton JPW, Lue TF, et al.American Urological Association guideline onthe management of priapism. The Journal ofUrology. 2003;170(4 Pt 1): 1318–1324. https://doi.org/10.1097/01.ju.0000087608.07371.ca.

  2. Broderick GA, Kadioglu A, Bivalacqua TJ,Ghanem H, Nehra A, Shamloul R. Priapism:pathogenesis, epidemiology, and management.The Journal of Sexual Medicine. 2010;7(1 Pt2): 476–500. https://doi.org/10.1111/j.1743-6109.2009.01625.x.

  3. Anele UA, Le BV, Resar LMS, Burnett AL.How I treat priapism. Blood. 2015;125(23):3551–3558. https://doi.org/10.1182/blood-2014-09-551887.

  4. Bivalacqua TJ, Allen BK, Brock GB, BroderickGA, Chou R, Kohler TS, et al. The Diagnosisand Management of Recurrent IschemicPriapism, Priapism in Sickle Cell Patients,and Non-Ischemic Priapism: An AUA/SMSNA Guideline. The Journal of Urology.2022;208(1): 43–52. https://doi.org/10.1097/JU.0000000000002767.

  5. Burnett AL. Pathophysiology of priapism:dysregulatory erection physiology thesis. TheJournal of Urology. 2003;170(1): 26–34. https://doi.org/10.1097/01.ju.0000046303.22757.f2.

  6. Arduini GAO, Trovó de Marqui AB. Prevalenceand Characteristics of Priapism in Sickle CellDisease. Hemoglobin. 2018;42(2): 73–77. https://doi.org/10.1080/03630269.2018.1452760.

  7. Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL.New insights into the pathophysiology of sicklecell disease-associated priapism. The Journal ofSexual Medicine. 2012;9(1): 79–87. https://doi.org/10.1111/j.1743-6109.2011.02288.x.

  8. Mantadakis E, Cavender JD, Rogers ZR, EwaltDH, Buchanan GR. Prevalence of priapism inchildren and adolescents with sickle cell anemia.Journal of Pediatric Hematology/Oncology.1999;21(6): 518–522.

  9. Capece M, La Rocca R, Mirone V, Bivalacqua TJ,Castiglione F, Albersen M, et al. A SystematicReview on Ischemic Priapism and ImmediateImplantation: Do We Need More Data? SexualMedicine Reviews. 2019;7(3): 530–534. https://doi.org/10.1016/j.sxmr.2018.10.007.

  10. Muneer A, Macrae B, Krishnamoorthy S, ZumlaA. Urogenital tuberculosis - epidemiology,pathogenesis and clinical features. NatureReviews. Urology. 2019;16(10): 573–598.https://doi.org/10.1038/s41585-019-0228-9.

  11. Salonia A, Eardley I, Giuliano F, HatzichristouD, Moncada I, Vardi Y, et al. EuropeanAssociation of Urology guidelines on priapism.European Urology. 2014;65(2): 480–489.https://doi.org/10.1016/j.eururo.2013.11.008.

  12. Mishra K, Loeb A, Bukavina L, BaumgartenA, Beilan J, Mendez M, et al. Management ofPriapism: A Contemporary Review. SexualMedicine Reviews. 2020;8(1): 131–139. https://doi.org/10.1016/j.sxmr.2019.01.001.

  13. Tricco AC, Lillie E, Zarin W, O’Brien KK,Colquhoun H, Levac D, et al. PRISMAExtension for Scoping Reviews (PRISMA-ScR):Checklist and Explanation. Annals of InternalMedicine. 2018;169(7): 467–473. https://doi.org/10.7326/M18-0850.

  14. Sedigh O, Rolle L, Negro CLA, Ceruti C,Timpano M, Galletto E, et al. Early insertionof inflatable prosthesis for intractable ischemicpriapism: our experience and review of theliterature. International Journal of ImpotenceResearch. 2011;23(4): 158–164. https://doi.org/10.1038/ijir.2011.23.

  15. Zacharakis E, De Luca F, Raheem AA, GaraffaG, Christopher N, Muneer A, et al. Earlyinsertion of a malleable penile prosthesis inischaemic priapism allows later upsizing ofthe cylinders. Scandinavian Journal of Urology.2015;49(6): 468–471. https://doi.org/10.3109/21681805.2015.1059359.

  16. Ralph DJ, Garaffa G, Muneer A, FreemanA, Rees R, Christopher AN, et al. Theimmediate insertion of a penile prosthesisfor acute ischaemic priapism. EuropeanUrology. 2009;56(6): 1033–1038. https://doi.org/10.1016/j.eururo.2008.09.044.

  17. Salem EA, El Aasser O. Management of ischemicpriapism by penile prosthesis insertion:prevention of distal erosion. The Journal ofUrology. 2010;183(6): 2300–2303. https://doi.org/10.1016/j.juro.2010.02.014.

  18. Rees RW, Kalsi J, Minhas S, Peters J, KellP, Ralph DJ. The management of low-flowpriapism with the immediate insertion of apenile prosthesis. BJU international. 2002;90(9):893–897. https://doi.org/10.1046/j.1464-410x.2002.03058.x.

  19. Zacharakis E, Garaffa G, Raheem AA,Christopher AN, Muneer A, Ralph DJ.Penile prosthesis insertion in patients withrefractory ischaemic priapism: early vs delayedimplantation. BJU international. 2014;114(4):576–581. https://doi.org/10.1111/bju.12686.

  20. Durazi MH, Jalal AA. Penile prosthesisimplantation for treatment of postpriapismerectile dysfunction. Urology Journal. 2008;5(2):115–119.

  21. Mireku-Boateng A, Jackson AG. Penileprosthesis in the management of priapism.Urologia Internationalis. 1989;44(4): 247–248.https://doi.org/10.1159/000281515.

  22. Tausch TJ, Zhao LC, Morey AF, Siegel JA,Belsante MJ, Seideman CA, et al. Malleablepenile prosthesis is a cost-effective treatmentfor refractory ischemic priapism. The Journal ofSexual Medicine. 2015;12(3): 824–826. https://doi.org/10.1111/jsm.12803.

  23. Upadhyay J, Shekarriz B, Dhabuwala CB. Penileimplant for intractable priapism associatedwith sickle cell disease. Urology. 1998;51(4):638–639. https://doi.org/10.1016/s0090-4295(97)00704-8.

  24. Bella A, Wang R, Shamloul R, ZappavignaC, Ahmed M, Sadeghi-Nejad H. 1859 3-pieceinflatable penile prosthesis insertion postT-shunt for priapism with dilation/corporalsnake maneuver and comparison to post alghorabshunt ipp outcomes. The Journal ofUrology. 2012; https://doi.org/10.1016/j.juro.2012.02.1971.

  25. Monga M, Broderick GA, Hellstrom WJ.Priapism in sickle cell disease: the case forearly implantation of the penile prosthesis.European Urology. 1996;30(1): 54–59. https://doi.org/10.1159/000474145.

  26. Olujohungbe A, Burnett AL. How I managepriapism due to sickle cell disease. BritishJournal of Haematology. 2013;160(6): 754–765.https://doi.org/10.1111/bjh.12199.

  27. Govier FE, Jonsson E, Kramer-LevienD. Oral terbutaline for the treatment ofpriapism. The Journal of Urology. 1994;151(4):878–879. https://doi.org/10.1016/s0022-5347(17)35111-x.

  28. Zacharakis E, Raheem AA, Freeman A,Skolarikos A, Garaffa G, Christopher AN, etal. The efficacy of the T-shunt procedure andintracavernous tunneling (snake maneuver)for refractory ischemic priapism. The Journalof Urology. 2014;191(1): 164–168. https://doi.org/10.1016/j.juro.2013.07.034.

  29. Ortaç M, Çevik G, Akdere H, Ermeç B, KadıoğluA. Anatomic and Functional Outcome FollowingDistal Shunt and Tunneling for Treatmentİschemic Priapism: A Single-Center Experience.The Journal of Sexual Medicine. 2019;16(8):1290–1296. https://doi.org/10.1016/j.jsxm.2019.05.011.

  30. Bennett N, Mulhall J. Sickle cell disease statusand outcomes of African-American menpresenting with priapism. The Journal of SexualMedicine. 2008;5(5): 1244–1250. https://doi.org/10.1111/j.1743-6109.2008.00770.x.

  31. Kulmala RV, Lehtonen TA, Lindholm TS,Tammela TL. Permanent open shunt as areason for impotence or reduced potency aftersurgical treatment of priapism in 26 patients.International Journal of Impotence Research.1995;7(3): 175–180.

  32. Fuchs JS, Shakir N, McKibben MJ, MathurS, Teeple S, Scott JM, et al. PenoscrotalDecompression-Promising New TreatmentParadigm for Refractory Ischemic Priapism. TheJournal of Sexual Medicine. 2018;15(5): 797–802.https://doi.org/10.1016/j.jsxm.2018.02.010.

  33. Winter CC. Priapism cured by creation offistulas between glans penis and corporacavernosa. The Journal of Urology. 1978;119(2):227–228. https://doi.org/10.1016/s0022-5347(17)57440-6.

  34. Segal RL, Readal N, Pierorazio PM, BurnettAL, Bivalacqua TJ. Corporal Burnett ‘Snake’surgical maneuver for the treatment of ischemicpriapism: long-term followup. The Journal ofUrology. 2013;189(3): 1025–1029. https://doi.org/10.1016/j.juro.2012.08.245.

  35. Wilson SK, Zumbe J, Henry GD, Salem EA,Delk JR, Cleves MA. Infection reduction usingantibiotic-coated inflatable penile prosthesis.Urology. 2007;70(2): 337–340. https://doi.org/10.1016/j.urology.2007.03.058.

  36. Wilson SK. Reimplantation of inflatable penileprosthesis into scarred corporeal bodies.International Journal of Impotence Research.2003;15 Suppl 5: S125-128. https://doi.org/10.1038/sj.ijir.3901086.

  37. Bozkurt İH, Yonguç T, Aydoğdu Ö, DeğirmenciT, Arslan M, Minareci S. Use of a microdebriderfor corporeal excavation and penile prosthesisimplantation in men with severely fibrosedcorpora cavernosa: a new minimal invasivesurgical technique. Turkish Journal of Urology.2015;41(3): 119–124. https://doi.org/10.5152/tud.2015.36539.

  38. Tsambarlis PN, Chaus F, Levine LA. SuccessfulPlacement of Penile Prostheses in Men WithSevere Corporal Fibrosis Following VacuumTherapy Protocol. The Journal of Sexual Medicine.2017;14(1): 44–46. https://doi.org/10.1016/j.jsxm.2016.11.304.




2020     |     www.medigraphic.com